{
  "scientific": "Trametes versicolor",
  "synonyms": [
    "Coriolus versicolor",
    "Polyporus versicolor"
  ],
  "pharmacopoeia_names": [
    "Yunzhi (TCM)",
    "Kawaratake (Kampo)"
  ],
  "description": "Turkey Tail is one of the best-researched medicinal mushrooms. The polysaccharides PSK (Krestin) and PSP derived from it are approved cancer medicines in Asia.",
  "traditional_medicine": {
    "systems": [
      "Traditional Chinese Medicine (TCM)",
      "Japanese Kampo Medicine"
    ],
    "historical_use": "Used in TCM for centuries as a tonic and to strengthen the immune system. In Japan, PSK was approved in 1977 as the first mushroom-based cancer medicine.",
    "traditional_indications": [
      "Strengthening the immune system",
      "Support during cancer therapy",
      "Chronic fatigue",
      "Infectious diseases"
    ]
  },
  "tcm_herb_name_pinyin": "Yunzhi",
  "tcm_herb_name_chinese": "云芝",
  "tcm_nature": "Slightly warm",
  "tcm_flavor": [
    "Sweet",
    "Slightly bitter"
  ],
  "tcm_meridian_tropism": [
    "Liver",
    "Spleen",
    "Lung"
  ],
  "tcm_therapeutic_actions": [
    "Strengthens Qi",
    "Eliminates dampness",
    "Clears heat",
    "Strengthens the spleen"
  ],
  "who_monograph_exists": false,
  "escop_monograph_exists": false,
  "active_substances": [
    "PSK (Polysaccharide-K, Krestin)",
    "PSP (Polysaccharide-Peptide)",
    "Beta-glucans",
    "Ergosterol",
    "Triterpenoids"
  ],
  "effect_profile": [
    {"axis": "Immunomodulation", "value": 95},
    {"axis": "Antitumoral", "value": 85},
    {"axis": "Antioxidant", "value": 70},
    {"axis": "Hepatoprotective", "value": 60},
    {"axis": "Antibacterial", "value": 50}
  ],
  "therapeutic_categories": [
    "Immunomodulator",
    "Biological cancer therapy adjuvant",
    "Adaptogen"
  ],
  "evidence_level": {
    "status": "Strong (Asia), Moderate (West)",
    "variant": "success"
  },
  "clinical_studies": [
    "Numerous RCTs in Japan and China on PSK/PSP for cancer",
    "Phase I studies on immune stimulation in breast cancer",
    "Studies on improved survival rates in gastric and colorectal cancer"
  ],
  "meta_analyses": [
    "Cochrane Reviews on PSK for gastric cancer show significant benefits"
  ],
  "safety_score": {
    "value": 85,
    "min": 0,
    "max": 100,
    "zones": [
      {"min": 0, "max": 30, "color": "red"},
      {"min": 30, "max": 70, "color": "yellow"},
      {"min": 70, "max": 100, "color": "green"}
    ]
  },
  "side_effects": [
    {"level": "trivial", "typ": "Gastrointestinal complaints", "beschreibung": "Rarely mild digestive discomfort"},
    {"level": "trivial", "typ": "Darkening of nails", "beschreibung": "Occasionally observed with PSK, reversible"}
  ],
  "interactions": [
    {"level": "moderate", "typ": "Immunosuppressants", "beschreibung": "Possible weakening of immunosuppressive therapies"},
    {"level": "trivial", "typ": "Chemotherapy", "beschreibung": "Specifically used as adjuvant"}
  ],
  "contraindications": [
    "Known mushroom allergy",
    "Severe autoimmune diseases (medical supervision required)",
    "Before surgery (discontinue 1-2 weeks prior)"
  ],
  "special_populations_pregnancy": {
    "status": "Insufficient data",
    "variant": "warning"
  },
  "special_populations_lactation": {
    "status": "Insufficient data",
    "variant": "warning"
  },
  "special_populations_children": {
    "status": "Caution advised",
    "variant": "warning"
  },
  "dosage_notes": "PSK is typically administered at 3 g/day orally. Extracts and powders vary by manufacturer.",
  "dosage_schemes": [
    {"amount": 3, "unit": "g", "frequency": "daily", "route": "oral", "notes": "PSK standard dose in clinical studies"},
    {"amount": 1, "unit": "g", "frequency": "2-3x daily", "route": "oral", "notes": "Typical supplement dosage"}
  ],
  "preparation_forms": [
    "PSK (Krestin) - approved medicine in Japan",
    "PSP - approved medicine in China",
    "Hot water extract",
    "Powder",
    "Capsules",
    "Tea"
  ],
  "status_by_region": {
    "eu": "Dietary supplement",
    "usa": "Dietary Supplement",
    "japan": "Approved medicine (PSK)",
    "china": "Approved medicine (PSP)",
    "canada": "Natural Health Product",
    "australia": "Complementary Medicine"
  },
  "novel_food": false,
  "drug_approvals": [
    "PSK (Krestin) - Japan 1977",
    "PSP - China 1987"
  ],
  "origin_wild_collection": {
    "available": true,
    "regions": [
      "Worldwide",
      "Europe",
      "North America",
      "Asia"
    ],
    "sustainability_concerns": "Common mushroom, no concerns with moderate collection"
  },
  "origin_cultivation": {
    "available": true,
    "regions": [
      "China",
      "Japan",
      "USA",
      "Europe"
    ],
    "methods": "Substrate cultivation on sawdust or wood"
  },
  "quality_differences": "Extracts vary greatly in polysaccharide content. Beta-glucan content should be standardized.",
  "patient_information": "Trametes versicolor is a well-tolerated medicinal mushroom with strong research basis for immune stimulation. Approved in Asia as adjuvant for cancer therapy.",
  "for_physicians": "PSK and PSP are the clinically best-studied mushroom polysaccharides. Randomized studies show improved survival rates in gastric and colorectal cancer in combination with chemotherapy.",
  "further_literature": {
    "authors": "Standish, L.J. et al.",
    "year": 2008,
    "title": "Trametes versicolor Mushroom Immune Therapy in Breast Cancer",
    "journal": "Journal of the Society for Integrative Oncology",
    "doi": "10.2310/7200.2008.0003"
  },
  "medical_score": {
    "rating": 9,
    "max": 10
  },
  "profile": "Immunomodulator with strong clinical evidence as adjuvant in cancer therapy",
  "evidence_grade_overall": {
    "status": "A (Asia), B (Western)",
    "variant": "success"
  }
}
